|
⚲
|
| Keyboard |
| Matthew Winkler | |
|---|---|
| Firm | Benefit Street Partners LLC |
| Address | 9 West 57th Street, Suite 4920 Suite 3400 New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Benefit Street Partners LLC | |||||
| Benefit Street Partners Special Situations Contingent Opportunities Fund LP | 021-429517 | Executive Officer | 117.1 M | ||
| Benefit Street Partners Special Situations Fund II Cayman Master LP | 021-429496 | Executive Officer | 180.2 M of 180.2 M |
230.0 M | |
| Benefit Street Partners Special Situations Fund II LP | 021-429492 | Executive Officer | 233.3 M of 233.3 M |
293.3 M | |
| Benefit Street Partners Special Situations Contingent Opportunities Fund Cayman LP | 021-429541 | Executive Officer | |||
| Akoya Biosciences Inc | 021-322630 | Director | 24.5 M of 25.5 M |
||
| Akoya Biosciences Inc | 021-290813 | Director | 9.0 M of 9.0 M |
||
| Mirna Therapeutics Inc | 021-239002 | Director | 41.8 M of 45.0 M |
||
| Asuragen Inc | 021-193625 | Executive Officer | 7.5 M of 15.0 M |
||
| Mirna Therapeutics Inc | 021-186414 | Director | 17.2 M of 34.5 M |
||
| Mirna Therapeutics Inc | 021-164825 | Director | 1.5 M of 1.5 M |
||
| Asuragen Inc | 021-164309 | Executive Officer | 5.0 M of 10.0 M |
||
| Second Genome Inc | 021-164097 | Director | 5.0 M of 5.0 M |
||